Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 4 | 2023 | 4664 | 0.750 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2023 | 547 | 0.680 |
Why?
|
| Flavoproteins | 1 | 2017 | 43 | 0.630 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2017 | 151 | 0.600 |
Why?
|
| Lymphocyte Activation | 2 | 2023 | 5519 | 0.390 |
Why?
|
| L-Amino Acid Oxidase | 2 | 2018 | 4 | 0.330 |
Why?
|
| Melanoma | 2 | 2023 | 5462 | 0.290 |
Why?
|
| Melanoma, Experimental | 2 | 2023 | 559 | 0.290 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2023 | 834 | 0.220 |
Why?
|
| Autoimmunity | 2 | 2021 | 1348 | 0.210 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 1837 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2023 | 542 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2017 | 122 | 0.150 |
Why?
|
| Epigastric Arteries | 1 | 2018 | 91 | 0.150 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2017 | 205 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2023 | 1284 | 0.150 |
Why?
|
| Tumor Burden | 1 | 2023 | 1905 | 0.150 |
Why?
|
| Receptors, Immunologic | 2 | 2020 | 1423 | 0.150 |
Why?
|
| Fibrinogen | 1 | 2020 | 894 | 0.150 |
Why?
|
| Glycolysis | 2 | 2021 | 825 | 0.140 |
Why?
|
| Antibody Formation | 1 | 2020 | 1402 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2020 | 2003 | 0.130 |
Why?
|
| Propranolol | 1 | 2016 | 502 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 534 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2016 | 341 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2021 | 765 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 2017 | 880 | 0.120 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3564 | 0.120 |
Why?
|
| Lymph Nodes | 2 | 2023 | 3465 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2023 | 5975 | 0.110 |
Why?
|
| Autoantibodies | 1 | 2020 | 2036 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2021 | 2986 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2020 | 14554 | 0.100 |
Why?
|
| Mice | 7 | 2023 | 81045 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 21821 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2016 | 1887 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 4438 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2502 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 2130 | 0.080 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 5662 | 0.080 |
Why?
|
| Mammaplasty | 1 | 2018 | 1195 | 0.080 |
Why?
|
| Animals | 9 | 2023 | 168561 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10163 | 0.070 |
Why?
|
| Models, Biological | 1 | 2021 | 9581 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 10578 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10472 | 0.060 |
Why?
|
| Macrophages | 1 | 2018 | 5655 | 0.060 |
Why?
|
| Neoplasms | 2 | 2023 | 21596 | 0.050 |
Why?
|
| Eflornithine | 1 | 2021 | 31 | 0.050 |
Why?
|
| Putrescine | 1 | 2021 | 40 | 0.050 |
Why?
|
| Aerobiosis | 1 | 2021 | 106 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11470 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 231 | 0.050 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 182 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2021 | 234 | 0.050 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2021 | 154 | 0.050 |
Why?
|
| Seroma | 1 | 2018 | 69 | 0.040 |
Why?
|
| Cytokines | 2 | 2023 | 7317 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2020 | 540 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2023 | 4414 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2187 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15244 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2016 | 220 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2018 | 360 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 2024 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2020 | 1200 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 23387 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 1368 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13655 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2021 | 1806 | 0.030 |
Why?
|
| Netherlands | 1 | 2018 | 2170 | 0.030 |
Why?
|
| Hematoma | 1 | 2018 | 755 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1606 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1038 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20774 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2020 | 4024 | 0.020 |
Why?
|
| Chromatin | 1 | 2021 | 2917 | 0.020 |
Why?
|
| Mastectomy | 1 | 2018 | 1789 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2020 | 5095 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4839 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10248 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11001 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8626 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13853 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19223 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
| Humans | 4 | 2023 | 742088 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 213127 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 213712 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 57683 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 72145 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 62966 | 0.010 |
Why?
|
| Female | 2 | 2018 | 379592 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 77098 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 162944 | 0.000 |
Why?
|
| Male | 1 | 2018 | 349538 | 0.000 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_